Morgan Stanley analyst Patrick Wood upgraded Solventum (SOLV) to Overweight from Equal Weight with a price target of $103, up from $80. The firm has increased confidence in Solventum hitting the mid-point of the 2028 guidance, suggesting EPS nearing $9 by that point along with essentially a cash neutral balance sheet, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum upgraded to Buy at Argus on topline growth over past few quarters
- Solventum upgraded to Buy from Hold at Argus
- Hold Rating Maintained for Solventum Corporation Amid Strategic P&F Business Transaction Adjustments
- Solventum Amends Acquisition Deal with Thermo Fisher
- Solventum initiated with a Sector Weight at KeyBanc